FINAL RESULTS FROM THE PHASE 3 REGENERATE TRIAL EVALUATING THE EFFECTS OF OBETICHOLIC ACID IN PATIENTS WITH PRE-CIRRHOTIC FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS

被引：0
|
作者：
Sanyal, Arun J.
Loomba, Rohit
Anstee, Quentin M.
Ratziu, Vlad
Kowdley, Kris V.
Lawitz, Eric
Berrey, M. Michelle
White, Christopher
Sawhney, Sangeeta
Capozza, Thomas
Leyva, Rina
Younossi, Zobair M.
Rinella, Mary
Abdelmalek, Manal F.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1057e
引用
收藏
页数：2
相关论文
共 50 条
  • [41] TOPLINE RESULTS FROM THE ALPINE 2/3 STUDY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 2b TRIAL EVALUATING 3 DOSES OF THE FGF19 ANALOGUE ALDAFERMIN ON LIVER HISTOLOGY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND STAGE 2 OR 3 FIBROSIS
    Harrison, Stephen A.
    Abdelmalek, Manal F.
    Neff, Guy W.
    Gunn, Nadege
    Guy, Cynthia D.
    Alkhouri, Naim
    Bashir, Mustafa
    Freilich, Bradley
    Almeda, Jose
    Knapple, Whitfield
    Kohli, Anita
    Khazanchi, Arun
    Sheikh, Muhammad Y.
    Leibowitz, Mark
    Hogan, Reed
    White, Judith
    Kayali, Zeid
    Rinella, Mary E.
    Siddiqui, Mohammad S.
    Kipnes, Mark
    Moussa, Sam E.
    Ortiz-Lasanta, Grisell
    Poulos, John
    Younes, Ziad
    Bansal, Meena B.
    Baum, Seth J.
    Borg, Brian
    Ruane, Peter J.
    White, Alexander
    Merkes, Kevin
    Rashmee, Patil
    Thuluvath, Paul J.
    Gottwald, Mildred
    Khan, Mujib
    Chen, Charles
    Yan, Andrew Z.
    Melchor-Khan, Liza
    Chang, William
    DePaoli, Alex
    Ling, Lei
    Lieu, Hsiao
    HEPATOLOGY, 2021, 74 : 5A - 6A
  • [42] RESMETIROM TREATMENT HELPS RESTORE THYROID HORMONE LEVELS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: 52-WEEK DATA FROM THE PHASE 3 MAESTRONASH TRIAL
    Harrison, Stephen A.
    Bedossa, Pierre
    Guy, Cynthia D.
    Schattenberg, Joern M.
    Loomba, Rohit
    Taub, Rebecca A.
    Labriola, Dominic
    Moussa, Sam
    Neff, Guy W.
    Sanyal, Arun
    Noureddin, Mazen
    Bansal, Meena B.
    Alkhouri, Naim
    Ratziu, Vlad
    HEPATOLOGY, 2023, 78 : S1213 - S1219
  • [43] EFFICACY AND SAFETY OF PEGBELFERMIN IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND STAGE 3 FIBROSIS: RESULTS FROM THE PHASE 2b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED FALCON 1 STUDY
    Loomba, Rohit
    Sanyal, Arun J.
    Nakajima, Atsushi
    Neuschwander-Tetri, Brent A.
    Goodman, Zachary
    Harrison, Stephen A.
    Lawitz, Eric J.
    Gunn, Nadege
    Imajo, Kento
    Ravendhran, Natarajan
    Akahane, Takemi
    Boone, Bradly
    Yamaguchi, Masayuki
    Chatterjee, Arkendu
    Tirucherai, Giridhar S.
    Shevell, Diane E.
    Du, Shuyan
    Charles, Edgar D.
    Abdelmalek, Manal F.
    HEPATOLOGY, 2021, 74 (06) : 1385A - 1386A
  • [44] Combined effect of obeticholic acid and bezafibrate in patients with primary biliary cholangitis and inadequate response or intolerance to ursodeoxycholic acid: 6-month results from a phase 2 trial
    Jones, David E.
    Louvet, Alexandre
    Corpechot, Christophe
    Hejda, Vaclav
    Zou, Heng
    Civitarese, Antonio
    Villamil, Alejandra
    Nevens, Frederik
    JOURNAL OF HEPATOLOGY, 2024, 80 : S91 - S91
  • [45] Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial (vol 394, pg 2184, 2019)
    Younossi, Z. M.
    Ratziu, V
    Loomba, R.
    LANCET, 2020, 396 (10247): : 312 - 312
  • [46] Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial
    N Raje
    S Vadhan-Raj
    W Willenbacher
    E Terpos
    V Hungria
    A Spencer
    Y Alexeeva
    T Facon
    A K Stewart
    A Feng
    A Braun
    A Balakumaran
    G D Roodman
    Blood Cancer Journal, 2016, 6 : e378 - e378
  • [47] Combined Effect of Obeticholic Acid and Bezafibrate in Patients With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid: 6-Month Results From a Phase 2 Trial
    Ballard, Meha
    Jones, David E.
    Louvet, Alexandre
    Corpechot, Christophe
    Hejda, Vaclav
    Zou, Heng
    Civitarese, Antonio
    Villamil, Alejandra
    Nevens, Frederick
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S82 - S83
  • [48] Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial
    Raje, N.
    Vadhan-Raj, S.
    Willenbacher, W.
    Terpos, E.
    Hungria, V.
    Spencer, A.
    Alexeeva, Y.
    Facon, T.
    Stewart, A. K.
    Feng, A.
    Braun, A.
    Balakumaran, A.
    Roodman, G. D.
    BLOOD CANCER JOURNAL, 2016, 6 : e378 - e378
  • [49] A NOVEL PATIENT-REPORTED OUTCOME MEASURE INDICATES LOW BURDEN OF TREATMENT AMONG PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: INTERIM RESULTS FROM A PHASE 2 TRIAL OF TROPIFEXOR
    Whalley, D.
    Twiss, J.
    Doward, L.
    Balp, Maria-Magdalena
    Brass, Clifford
    Tietz, Andreas
    Loeffler, Juergen
    Lopez, Patricia
    Lawitz, Eric J.
    Sanyal, Arun J.
    HEPATOLOGY, 2020, 72 : 1005 - 1005
  • [50] POSITIVE RESULTS FROM THE ALPINE 4 STUDY: A RANDOMIZED, DOUBLE- BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 2b TRIAL EVALUATING MULTIPLE DOSES OF THE FGF19 ANALOGUE ALDAFERMIN IN PATIENTS WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS
    Rinella, Mary
    Lieu, Hsiao
    Kowdley, Kris V.
    Goodman, Zachary D.
    Alkhouri, Naim
    Lawitz, Eric
    Ratziu, Vlad
    Abdelmalek, Manal F.
    Wong, Vincent Wai-Sun
    Younes, Ziad
    Ortiz-Lasanta, Grisell
    Sheikh, Aasim
    Brannan, Donald
    Freilich, Bradley
    Pianko, Stephen
    Neff, Guy W.
    Membreno, Fernando
    Sinclair, Marie
    Ankoma-Sey, Victor
    Borg, Brian
    Heneghan, Michael A.
    LeMire, Marc
    Schiefke, Ingolf
    Thuluvath, Paul J.
    Melchor-Khan, Liza
    Anstee, Quentin M.
    Tacke, Frank
    Sanyal, Arun
    Ling, Lei
    Harrison, Stephen A.
    HEPATOLOGY, 2023, 78 : S12 - S16
12345